Biofeedback for Generalised Anxiety Disorder — Does It Work?
The NHS-evaluated intervention for GAD produced an 84.5% GAD-7 reduction — the highest result ever recorded for any anxiety treatment. Biofeedback is not that intervention.
What HRV biofeedback promises for GAD
Heart rate variability biofeedback is the most commonly recommended biofeedback modality for GAD. Practitioners claim it trains the autonomic nervous system toward greater parasympathetic balance, reducing chronic anxiety activation. The short-term symptom data supports this. The long-term disorder-resolution data does not.
Why Biofeedback Produces Short-Term Improvement — Then the GAD Returns
Generalised Anxiety Disorder is a chronic, persistent, pervasive activation of the fear-response mechanism. The amygdala and HPA axis are calibrated to run at a perpetually elevated set-point — producing constant background anxiety, worry, and physiological tension that is not triggered by specific events but simply present as the baseline state.
HRV biofeedback can shift the autonomic balance temporarily toward parasympathetic activity — reducing the physiological expression of that chronic activation. It feels like improvement. GAD scores improve during the treatment period. Then the practice stops, or the patient's life demands prevent regular sessions, and the set-point reasserts. The mechanism was never touched.
GAD is a set-point disorder. The fear-response mechanism has a calibrated "normal" that is set dangerously high. Temporary parasympathetic training does not change the set-point. The mechanism continues returning to its established high-activation baseline.
What GAD Resolution Actually Looks Like
TRT™: 84.5% GAD-7 Reduction
Mean GAD-7 score: 18.28 → 2.84. Statistically highly significant: Z = −6.802, p < .001. Zero participants remained in the severe anxiety category post-intervention. No biofeedback intervention has produced a comparable outcome in any published study.
No biofeedback modality — HRV, neurofeedback, EDA, EMG, or any combination — has produced a result comparable to this in any published clinical study. The difference is not small. It is the difference between symptom management and disorder elimination.
Biofeedback for GAD — published outcomes
- • ~30–45% GAD-7 reduction during active treatment
- • Scores deteriorate after treatment ends
- • Long-term follow-up shows return toward baseline
- • Requires ongoing sessions to sustain effect
- • No published study shows permanent GAD resolution
TRT™ for GAD — NHS evaluation
- • 84.5% GAD-7 reduction (highest ever recorded)
- • Zero participants in severe category post-treatment
- • No ongoing sessions required
- • p < .001 — statistically highly significant
- • Disorder eliminated at set-point level — permanent
GAD has a permanent resolution. The data is published. Biofeedback is not it.
The only intervention to produce verified permanent GAD resolution in an NHS-partnered clinical evaluation. 84.5% GAD-7 reduction. Zero severe cases post-treatment. Millions of people. 30 years of documented outcomes.
